Add BrightSurf on Google Email

How the brain controls its blood volume

Researchers discovered a two-step mechanism where inhibitory neurons release nitric oxide to rapidly dilate blood vessels, followed by slower, localized vasodilation via astrocyte activation. This breakthrough sheds light on how neural signals are translated into blood volume changes in brain imaging.

SourceInstitute for Basic Science·JournalNature Communications·TypeExperimental study·DateJul 21, 2025

NTU Singapore and Oxford scientists reveal how cells repair toxic DNA damage linked to cancer and premature ageing

Researchers at NTU Singapore and Oxford University have discovered a mechanism by which cells identify and repair highly toxic DNA damage, known as DPCs, that cause cancer, neurodegeneration, and premature ageing. The study reveals how SPRTN, a key repair enzyme, selectively targets DPC lesions, increasing its activity 67-fold.

SourceNanyang Technological University·JournalNucleic Acids Research·TypeExperimental study·DateJul 21, 2025

Weekly injection could be life changing for Parkinson’s patients

Scientists at University of South Australia developed a long-acting injectable formulation that delivers levodopa and carbidopa over a week, reducing the need for multiple daily tablets. The biodegradable formulation improves treatment outcomes and patient compliance, offering a potential game-changer for Parkinson's care.

SourceUniversity of South Australia·JournalDrug Delivery and Translational Research·TypeExperimental study·DateJul 13, 2025

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

A new treatment method using microglia replacement has shown promising results in halting the progression of genetic neurological disease ALSP in both mice and human individuals. The treatment, developed at Fudan University, successfully replaced mutated microglia with healthy ones, improving neurological function and extending life ex...

SourceFudan University·JournalScience·TypeExperimental study·DateJul 10, 2025

New study maps four key pathways to Alzheimer’s disease

Researchers identified four distinct pathways leading to Alzheimer's disease, revealing how conditions progress step-by-step toward the condition. The study validated findings in a nationally diverse population, suggesting that understanding these pathways could fundamentally change how clinicians approach early detection and prevention.

SourceUniversity of California - Los Angeles Health Sciences·JournalEBioMedicine·TypeData/statistical analysis·DateJul 7, 2025

Non-invasive vagus nerve stimulation for the treatment of neurological and psychiatric disorders

Non-invasive vagus nerve stimulation (nVNS) has demonstrated efficacy in reducing seizure frequency, improving mood, and enhancing motor recovery in various conditions. Future research should prioritize standardized protocols, large-scale trials, and biomarker development to personalize treatment.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateJul 7, 2025

A perfect fit: A Chinese Neurosurgical Journal study shows that Neuroform Atlas stent-assisted coiling is effective even in smaller arteries

A study published in Chinese Neurosurgical Journal found that the Neuroform Atlas stent-assisted coiling procedure is safe and effective for treating intracranial aneurysms in arteries less than 2.5 mm in diameter, with favorable outcomes and low postoperative complication rates.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeData/statistical analysis·DateJul 3, 2025

Forging a novel therapeutic path for patients with Rett Syndrome using AI

Researchers at the Wyss Institute have identified vorinostat as a promising treatment for Rett Syndrome using an AI-driven drug discovery process and innovative disease modeling. The findings demonstrate disease-modifying abilities across multiple tissues, offering hope for a potentially curative treatment.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalCommunications Medicine·TypeComputational simulation/modeling·DateJul 2, 2025

Financing innovation: proposal for novel adaptive platform trial fund offers new model for ALS drug development

A team of researchers proposes a novel adaptive platform trial fund to accelerate ALS drug development. The study outlines a financing model that merges efficiencies with an innovative royalty-based investment structure, drawing on data from the HEALEY ALS Platform Trial. This new approach could transform how diseases like ALS are addr...

SourceMIT Sloan School of Management·JournalPLOS One·TypeComputational simulation/modeling·DateJul 2, 2025

New MRI approach maps brain metabolism, revealing disease signatures

Researchers at the University of Illinois Urbana-Champaign have developed a new non-invasive MRI approach that visualizes brain metabolism and detects metabolic alterations associated with brain diseases. The technique uses magnetic resonance spectroscopic imaging to provide insights into brain function and disease processes.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalNature Biomedical Engineering·TypeExperimental study·DateJul 1, 2025

Epilepsy self-management program shows promise to control seizures, improve mood and quality of life

A new study published in Epilepsy & Behavior found that a self-management program for people with epilepsy can reduce health complications, improve mood, and enhance quality of life. The program, called SMART, features remote training sessions and written resource materials to help participants manage their condition.

SourceCase Western Reserve University·JournalEpilepsy & Behavior·TypeRandomized controlled/clinical trial·DateJul 1, 2025

Optimizing surgical strategies through a nationwide trial: insights from a Chinese Neurosurgical Journal study

A landmark national study in China identifies the most effective treatment strategies for unruptured brain aneurysms, analyzing over 874,000 clinical entries and 42,000 radiological scans. The trial aims to guide patient-specific treatment strategies and inform healthcare planning in China's aging population.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeRandomized controlled/clinical trial·DateJun 30, 2025

UCLA researchers uncover key mechanism of brain repair in vascular dementia, revealing promising therapeutic target

Researchers at UCLA Health have made a groundbreaking discovery about the mechanisms underlying vascular dementia. They found that targeting inflammation in brain blood vessels can promote brain repair and functional recovery in mice. This breakthrough highlights a potential new treatment approach for this understudied form of dementia.

SourceUniversity of California - Los Angeles Health Sciences·JournalCell·TypeExperimental study·DateJun 30, 2025

A new timeline for Parkinson's disease

Researchers at La Jolla Institute for Immunology discovered that T cell reactivity is highest during the prodromal period in Parkinson's disease, which can last for decades before noticeable symptoms. This finding may guide the development of early diagnostic tools and provide a new timeline for Parkinson's disease detection.

SourceLa Jolla Institute for Immunology·Journalnpj Parkinson s Disease·TypeExperimental study·DateJun 18, 2025

Multiple sclerosis: Triggers in the gut flora

A study of twins reveals that certain bacteria in the small intestine may trigger MS. Researchers identified two specific bacteria, Lachnoclostridium sp and Eisenbergiella tayi, which are associated with the disease. The findings suggest a new potential therapeutic target for MS treatment.

SourceMax-Planck-Gesellschaft·JournalProceedings of the National Academy of Sciences·DateJun 5, 2025

Annual Alzheimer's clinical trials pipeline report shows increased reason for optimism

The annual Alzheimer's disease drug development pipeline report, led by Dr. Jeffrey Cummings, highlights an increase in active clinical trials and promising drugs, offering reason for optimism. The report assesses 138 drugs currently being studied and notes the growing importance of biomarkers in clinical trials.

SourceUniversity of Nevada, Las Vegas·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·TypeSystematic review·DateJun 3, 2025

International study: Asthma drug could help to treat a rare neurological disorder

A new study published by Martin-Luther-Universität Halle-Wittenberg found that theophylline significantly improved symptoms and quality of life for patients with ADCY5-related dyskinesia. The treatment yielded impressive results, including reduced muscle twitches, improved gait, and better psychosocial well-being.

SourceMartin-Luther-Universität Halle-Wittenberg·JournalMovement Disorders·TypeExperimental study·DateJun 3, 2025